VTVT
vTv Therapeutics Inc
30.20$
-1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -100.0% | – | – | -100.0% | – | – | – | – | -100.0% | – | |
| – | +4.5% | -4.3% | +4.5% | -4.3% | +0.0% | -59.1% | -66.7% | – | – | -50.0% | – | – | |
| – | – | – | -102.3% | – | – | – | – | – | – | – | – | – | |
| – | -24.3% | +23.9% | +29.8% | -6.3% | -30.7% | +26.7% | +45.0% | +71.1% | -44.3% | +129.7% | -2.3% | – | |
| – | +1.0% | +54.8% | -6.6% | -11.7% | -18.5% | +37.3% | -1.5% | +1.7% | +8.1% | +15.6% | +12.2% | – | |
| – | -12.3% | +40.8% | +8.0% | -9.1% | -24.9% | +33.1% | +18.7% | +38.6% | -26.3% | +72.2% | +2.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -159.9% | – | |
| – | +75.0% | – | – | – | – | – | – | – | -80.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -154.1% | – | |
| – | – | – | -1,329.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -154.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -154.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.